A Study of Degarelix in Taiwanese Patients With Prostate Cancer

Clinical trial NCT01220869 · COMPLETED

Trial details

NCT number: NCT01220869
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2010-12-01
Primary completion: 2012-10-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.